GMP manufacturing completed, paediatric waiver granted, positive outcome from FDA and EMA interactions; advancing mitazalimab toward Phase 3 readinessBiomarker data from OPTIMIZE-1 presented at ASCO, ...

Half Year ReportHeidelberg Pharma Reports on First Half-Year 2025 and the Positive Course of Business 10.07.2025 / 07:03 CET/CESTThe issuer is solely responsible for the content of this ...

StudyFormycon successfully completes patient enrollment for the clinical development of its Keytruda® biosimilar candidate FYB206 10.07.2025 / 06:30 CET/CESTThe issuer is solely responsible for the ...

UniDoc showcases its ongoing humanitarian and healthcare innovation efforts at international event in Rome, Italy VANCOUVER, BC / ACCESS Newswire / July 9, 2025 / UniDoc Health Corp.

Monroe County Hospital increases swing bed program census by 21% in less than 12 months, then up to 40% after 18 months. WATKINSVILLE, GA / ACCESS Newswire / July 9, 2025 / Inpatient beds that can ...

First comprehensive sell-side report on TRNR cites more than 800% growth in expected 2025 revenueValuation driven by stock-for-stock M&A model and potential crypto-treasury upside AUSTIN, TEXAS / ...

DUBAI, AE / ACCESS Newswire / July 9, 2025 / Keeping up the pace of your wellness process might seem like a chore, especially ...

UPPSALA, SWEDEN / ACCESS Newswire / July 9, 2025 / Senzime (STO:SEZI)(OTCQX:SNZZF) today announced that its licensee, Fukuda Denshi, has received FDA and UKCA approvals to launch its integrated HN-100 ...

The global Esoteric Testing Market is valued at USD 30.56 billion in 2024 and is projected to reach a value of USD 84.12 ...

Medtronic receives CE Mark for VitalFlow™ ECMO System, ushering in a new era of critical care in EuropeMedtronic expands its cardiac surgical and respiratory innovation portfolio with the launch of ...

Transplants can be life-saving – but for many, the journey doesn’t end there. Up to 40% of people receiving a stem cell or bone marrow transplant will go on to develop a serious complication known as ...

Novo Nordisk invests €2.34B to expand its Anagni facility near Rome, enhancing production of diabetes and obesity treatments ...